Markets news
FractLab market briefs
Tomra shares sink 6% as France abandons mandatory deposit-return plan
Tomra Systems shares fell more than 6% after France dropped its mandatory deposit-return scheme, opting for fl…
Read More
SigmaRoc shares jump 12% on profit rise and acquisition deal
SigmaRoc shares surged over 12% after the company reported higher first-half adjusted pretax profit and announ…
Read More
IQE stock climbs as H1 results show 43% revenue jump and EBITDA swing to profit
IQE shares rose after the company reported a 43% increase in first-half revenue and a return to adjusted EBITD…
Read More
Why is Ashmore stock sliding today?
Ashmore shares fell despite a 27% rise in attributable profit, as a sharp drop in performance fees and weaker…
Read More
Thailand Inflation Accelerates to 2.53% in August, Stays Within Target
Thailand’s consumer price index jumped 2.53% year-on-year in August, up from 1.95% in July and above the 2.43%…
Read More
Bernstein cautions rising U.S. yields remain an underpriced threat to Asian equities
Bernstein warns that U.S. Treasury yields approaching 5% are not fully reflected in Asian equity valuations, l…
Read More
Ferrexpo shares surge on production restart and listing reinstatement
Ferrexpo stock jumped more than 33% after the iron-ore producer restarted Ukrainian operations, completed a $1…
Read More
Why is Novartis stock sliding today?
Novartis AG shares are down 3.5% after its Phase III Lp(a)HORIZON trial for pelacarsen failed to meet the prim…
Read More
Ferrexpo Shares Surge 36% After Resuming Ukraine Production Thanks to $100M Fundraise
Ferrexpo shares soared over 36% on Monday after the Ukrainian iron ore producer restarted production over the…
Read More
Indonesian Shares End Lower as IDX Composite Retreats 0.16%
Indonesian stocks fell on Monday, with the IDX Composite closing down 0.16% as financial, infrastructure, and…
Read More
DAX Puts 200-SMA to the Test Following Head-and-Shoulders Breakdown
DAX sits near its 200-period SMA after a head-and-shoulders breakdown, with bears favored unless 26,200 resist…
Read More
Novartis stock slides as late-stage trial for experimental heart drug misses key goal
Novartis shares fell over 3% Monday after its experimental drug pelacarsen failed a pivotal cardiovascular tri…
Read More